drug allergy
drug allergy
Explore linked clinical trials. Standard reference: MONDO:000077528 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer | Adnexal Diseases, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, drug allergy, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, uterine disorder | Recruiting | Not applicable | 2026-10-07 | NCT06977594 | |
| Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Immediate, anaphylaxis, drug allergy, immune system disorder | Recruiting | Phase 2 | 2026-09-04 | NCT06406114 | |
| Subconjunctival Humira for Boston Keratoprosthesis | Chemically-Induced Disorders, Conjunctival Diseases, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Erythema, Hypersensitivity, Delayed, Pemphigoid, Benign Mucous Membrane, Skin and Connective Tissue Diseases, Stevens-Johnson syndrome, Stomatognathic Diseases, dermatitis, drug allergy, erythema multiforme, eye disorder, immune system disorder, mouth disorder, ocular cicatricial pemphigoid, skin disorder, stomatitis, vesiculobullous skin disease | Not yet recruiting | Phase 1 | 2026-08-31 | NCT06926478 | |
| Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease | Asthma, Aspirin-Induced, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Immediate, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, asthma, bronchial disorder, drug allergy, immune system disorder, nasal cavity polyp, nasal disorder, otorhinolaryngologic disease, polyp, respiratory system disorder | Active, not recruiting | Phase 2 | 2026-08-13 | NCT05575037 | |
| Interest of a Targeted Therapy for the Treatment of a Severe Form of Hypersensitivity to Drug (DRESS Syndrome) | Chemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Delayed, Skin and Connective Tissue Diseases, dermatitis, drug allergy, drug rash with eosinophilia and systemic symptoms, immune system disorder, skin disorder | Not yet recruiting | Phase 2 | 2026-05-15 | NCT06734884 | |
| Post-market Safety Study of LUMISIGHT | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Immediate, Neoplasms by Site, Skin and Connective Tissue Diseases, anaphylaxis, breast disorder, breast neoplasm, drug allergy, immune system disorder, neoplasm, skin disorder | Not yet recruiting | Not stated | 2026-05-07 | NCT07572162 | |
| Provocation After Nurse-Directed Assessment (PANDA) Study | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, drug allergy | Recruiting | Not stated | 2026-04-29 | NCT07127835 | |
| Origin and Function of Eosinophilic Polynuclear During DRESS Syndrome | Chemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Delayed, Skin and Connective Tissue Diseases, dermatitis, drug allergy, drug rash with eosinophilia and systemic symptoms, immune system disorder, skin disorder | Recruiting | Not stated | 2026-04-22 | NCT04330118 | |
| TAR-0520 Gel in Hand and Foot Syndrome | Chemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Skin and Connective Tissue Diseases, dermatitis, drug allergy, hand-foot syndrome, skin disorder | Not yet recruiting | Phase 2 | 2026-03-09 | NCT07457671 | |
| Establishment of a Registry for Immediate Drug Allergy | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, drug allergy | Not yet recruiting | Not stated | 2026-02-05 | NCT07390370 | |
| The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome | Chemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, dermatitis, drug allergy, hand-foot syndrome, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-02-02 | NCT05165069 | |
| Traditional Chinese Medicine Hand-Foot Soak for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome | Chemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Skin and Connective Tissue Diseases, dermatitis, drug allergy, hand-foot syndrome, skin disorder | Not yet recruiting | Not stated | 2026-01-29 | NCT07375446 | |
| HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-Effectiveness | Arthritis, Gouty, Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Erythema, Hypersensitivity, Delayed, Hyperuricemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Stevens-Johnson syndrome, Stomatognathic Diseases, arthritic joint disease, arthropathy, dermatitis, drug allergy, erythema multiforme, gout, hereditary disease, immune system disorder, inborn disorder of purine or pyrimidine metabolism, inborn errors of metabolism, metabolic disease, mouth disorder, musculoskeletal system disorder, rheumatic disorder, skin disorder, stomatitis, vesiculobullous skin disease | Not yet recruiting | Phase 4 | 2026-01-27 | NCT07369622 | |
| Analysis of the Role of IgE Proteoforms in Health and Disease | Bruton-type agammaglobulinemia, Chemically-Induced Disorders, Chronic Disease, Disease Attributes, Drug-Related Side Effects and Adverse Reactions, Hereditary alpha-tryptasemia, Hereditary alpha-tryptasemia syndrome, Hypersensitivity, Immediate, Mast Cell Activation Disorders, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, anaphylaxis, chronic urticaria, connective tissue neoplasm, drug allergy, immune system disorder, mastocytosis, neoplasm, skin disorder, skin vascular disease, urticaria, venom allergy | Recruiting | Not stated | 2026-01-09 | NCT07328178 | |
| Support Tool for Antibiotic Allergy deLabeling | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, drug allergy | Recruiting | Not applicable | 2025-12-16 | NCT06771440 | |
| Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients | Chemically-Induced Disorders, Digestive System Diseases, Digestive System Neoplasms, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Skin and Connective Tissue Diseases, colonic disorder, colorectal neoplasm, dermatitis, digestive system disorder, digestive system neoplasm, drug allergy, esophageal cancer, esophageal disorder, hand-foot syndrome, intestinal disorder, neoplasm, rectal disorder, skin disorder | Recruiting | Not stated | 2025-08-11 | NCT07114627 | |
| New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies. | Chemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Erythema, Hypersensitivity, Delayed, Skin and Connective Tissue Diseases, Stevens-Johnson syndrome, Stomatognathic Diseases, dermatitis, drug allergy, erythema multiforme, immune system disorder, mouth disorder, skin disorder, stomatitis, vesiculobullous skin disease | Not yet recruiting | Phase 1 / Phase 2 | 2025-08-07 | NCT07110662 | |
| LYell SYndrome MEsenchymal Stromal Cells Treatment | Chemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Erythema, Hypersensitivity, Delayed, Skin and Connective Tissue Diseases, Stevens-Johnson syndrome, Stomatognathic Diseases, dermatitis, drug allergy, erythema multiforme, immune system disorder, mouth disorder, skin disorder, stomatitis, vesiculobullous skin disease | Recruiting | Phase 1 / Phase 2 | 2025-08-01 | NCT04711200 | |
| Autologous Serum Obtained by a Closed-Circuit Collection Device | Chemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Erythema, Hypersensitivity, Delayed, Meibomian Gland Dysfunction, Skin and Connective Tissue Diseases, Stevens-Johnson syndrome, Stomatognathic Diseases, dermatitis, drug allergy, erythema multiforme, eye disorder, eyelid disorder, graft versus host disease, immune system disorder, mouth disorder, skin disorder, stomatitis, vesiculobullous skin disease | Not yet recruiting | Phase 2 | 2025-06-10 | NCT07014059 | |
| In Search of the Correct Diagnosis of Beta-lactam Allergy: From the Validation of a Risk Stratification Tool to Accurate Endotyping | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, drug allergy | Not yet recruiting | Not applicable | 2025-06-08 | NCT07011212 | |
| Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, drug allergy | Recruiting | Phase 3 | 2025-05-01 | NCT06303128 | |
| Cyclosporine Vs Steroids in DRESS | Chemically-Induced Disorders, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Hypersensitivity, Delayed, Skin and Connective Tissue Diseases, dermatitis, drug allergy, drug rash with eosinophilia and systemic symptoms, immune system disorder, skin disorder | Enrolling by invitation | Early phase 1 | 2025-03-30 | NCT04988256 | |
| Teicoplanin Allergy Testing Using Autologous Serum (TATAS) | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, drug allergy | Recruiting | Not applicable | 2025-01-31 | NCT06803758 | |
| Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome | Cancer of Gastrointestinal Tract, Chemically-Induced Disorders, Digestive System Diseases, Digestive System Neoplasms, Drug Eruptions, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, dermatitis, digestive system disorder, digestive system neoplasm, drug allergy, hand-foot syndrome, neoplasm, skin disorder | Recruiting | Not applicable | 2024-12-12 | NCT06602167 | |
| High Dimensional Analysis of Immune Cells in Pediatric Patients | Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, drug allergy | Recruiting | Not stated | 2024-11-29 | NCT05820802 |